Research Article

Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals

Volume: 14 Number: 2 June 1, 2024
EN

Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals

Abstract

Multiple sclerosis (MS) is a prevalent neurological disease with a global impact on patients' lives. Our study aimed to conduct a bibliometric analysis of research published in the field of pharmacology over the past decade. We retrieved original articles on MS from pharmacology journals in the last ten years through the Scopus database. The collected data underwent analysis using VOSViewer software, examining relationships between studies based on parameters such as citation, authorship, and organizations. In our country-based analysis, the United States emerged with the highest document count, totaling 350, followed by Germany with 210 documents. Claudio Viegas holds the top position with four publications in the last decade. The most prolific organization identified was associated with the Biogen-Cambridge-MA-United States group. However, Chulalongkorn University in Bangkok, Thailand, specifically the Department of Psychiatry, received the most citations. The most cited document was "Therapeutic Advances in Neurological Disorders," while the study with the highest citations was Ferreria-Vieira et al.'s (2016) work published in Current Neuropharmacology. Research efforts on MS treatment are evidently growing, with diverse research groups contributing worldwide. We anticipate that our study will provide valuable guidance to researchers in the field by shedding light on significant research and their interconnections in recent years.

Keywords

Supporting Institution

This research received no external funding.

Ethical Statement

The study does not require ethical approval. However, as authors, we declare that we act in accordance with the Publication Ethics.

References

  1. Albuquerque, P. C., Castro, M. J. C., Santos-Gandelman, J., Oliveira, A. C., Peralta, J. M., & Rodrigues, M. L. (2017). Bibliometric indicators of the Zika outbreak. PLoS neglected tropical diseases, 11(1), e0005132.
  2. Aleixandre-Benavent, R., Alonso-Arroyo, A., Gonzalez de Dios, J., Vidal-Infer, A., Gonzalez-Munoz, M., & Sempere, A. P. (2015). Bibliometric profile of the global scientific research on multiple sclerosis (2003-2012). Mult Scler, 21(2), 235-245. doi:10.1177/1352458514540357
  3. Alryalat, S. A. S., Malkawi, L. W., & Momani, S. M. (2019). Comparing bibliometric analysis using PubMed, Scopus, and Web of Science databases. JoVE (Journal of Visualized Experiments)(152), e58494.
  4. Amin, M., & Hersh, C. M. (2023). Updates and advances in multiple sclerosis neurotherapeutics. Neurodegener Dis Manag, 13(1), 47-70. doi:10.2217/nmt-2021-0058
  5. Aria, M., & Cuccurullo, C. (2017). bibliometrix: An R-tool for comprehensive science mapping analysis. Journal of informetrics, 11(4), 959-975.
  6. Aykaç, S., & Eliaçık, S. (2022). What are the trends in the treatment of multiple sclerosis in recent studies?–A bibliometric analysis with global productivity during 1980–2021. Multiple Sclerosis and Related Disorders, 68, 104185.
  7. Demir, E., Akmeşe, Ö. F., Erbay, H., Taylan-Özkan, A., & Mumcuoğlu, K. Y. (2020). Bibliometric analysis of publications on house dust mites during 1980–2018. Allergologia et immunopathologia, 48(4), 374-383.
  8. Dobson, R., & Giovannoni, G. (2019). Multiple sclerosis - a review. Eur J Neurol, 26(1), 27-40. doi:10.1111/ene.13819 Donthu, N., Kumar, S., Mukherjee, D., Pandey, N., & Lim, W. M. (2021). How to conduct a bibliometric analysis: An overview and guidelines. Journal of business research, 133, 285-296.

Details

Primary Language

English

Subjects

Software Engineering (Other)

Journal Section

Research Article

Early Pub Date

May 28, 2024

Publication Date

June 1, 2024

Submission Date

December 8, 2023

Acceptance Date

February 1, 2024

Published in Issue

Year 2024 Volume: 14 Number: 2

APA
Özkan, M., Yüksel, T. N., & Tozoğlu, F. (2024). Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. Journal of the Institute of Science and Technology, 14(2), 642-649. https://doi.org/10.21597/jist.1402305
AMA
1.Özkan M, Yüksel TN, Tozoğlu F. Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. J. Inst. Sci. and Tech. 2024;14(2):642-649. doi:10.21597/jist.1402305
Chicago
Özkan, Mazhar, Tuğba Nurcan Yüksel, and Fatih Tozoğlu. 2024. “Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals”. Journal of the Institute of Science and Technology 14 (2): 642-49. https://doi.org/10.21597/jist.1402305.
EndNote
Özkan M, Yüksel TN, Tozoğlu F (June 1, 2024) Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. Journal of the Institute of Science and Technology 14 2 642–649.
IEEE
[1]M. Özkan, T. N. Yüksel, and F. Tozoğlu, “Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals”, J. Inst. Sci. and Tech., vol. 14, no. 2, pp. 642–649, June 2024, doi: 10.21597/jist.1402305.
ISNAD
Özkan, Mazhar - Yüksel, Tuğba Nurcan - Tozoğlu, Fatih. “Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals”. Journal of the Institute of Science and Technology 14/2 (June 1, 2024): 642-649. https://doi.org/10.21597/jist.1402305.
JAMA
1.Özkan M, Yüksel TN, Tozoğlu F. Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. J. Inst. Sci. and Tech. 2024;14:642–649.
MLA
Özkan, Mazhar, et al. “Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals”. Journal of the Institute of Science and Technology, vol. 14, no. 2, June 2024, pp. 642-9, doi:10.21597/jist.1402305.
Vancouver
1.Mazhar Özkan, Tuğba Nurcan Yüksel, Fatih Tozoğlu. Bibliometric Analysis of Multiple Sclerosis Studies in Pharmacology Journals. J. Inst. Sci. and Tech. 2024 Jun. 1;14(2):642-9. doi:10.21597/jist.1402305